The piperazinyl-based Cu(II)-Schiff base complex {[Cu(HL1′)(N3)]2∙(ClO4)2·4H2O} (1) [HL1′ is the Zwitter ionic form of (E)-2-((2-piperazin-1-ylethylimino)methyl)phenol] was synthesized and characterized by spectroscopic and single crystal X-ray diffraction studies. The X-ray single crystal structure analysis shows that the asymmetric unit of 1 contains a four-coordinate discrete complex cation, [Cu(HL1′)(N3)]+ (1a), with a perchlorate anion and a lattice water molecule. Two square planar units of 1a are dimerized by weak Cu···N intermolecular interaction, forming [Cu(HL1′)(N3)]2 2+ (1′a). DFT and TD-DFT calculations of the monomeric cationic unit, [Cu(HL1′)(N3)]+ (1a) were performed. In-silico antibacterial activities of HL1 as well as monomeric and dimeric cationic units 1a and 1'a, respectively, were performed and study shows that 1a (EC50 0.30 μM) and 1′a (EC50 0.06 μM) may be treated as antibacterial drugs after in-vivo analysis and clinical testing.
Read full abstract